Skip to content

Search

Showing results for "Childhood interstitial lung disease "

Investigating the relationships between sun exposure and cardiometabolic dysfunction

Peter Shelley Jacoby Gorman BA (Hons) MSc BSc (Hons) PhD Biostatistician Honorary Research Associate Peter.Jacoby@thekids.org.au shelley.gorman@

National Antimicrobial Surveillance Academy for Indigenous Health Care Providers

Asha Bowen BA MBBS DCH FRACP PhD GAICD FAHMS OAM Head, Healthy Skin and ARF Prevention Head, Healthy Skin and ARF Prevention Areas of expertise: Skin

The PLAN Project (Pregnancy Lifestyle Activity and Nutrition)

Susan Prescott MBBS BMedSci PhD FRACP Honorary Research Fellow susan.prescott@thekids.org.au Honorary Research Fellow Susan Prescott is a Professor

Communication key to successful school transition

This time last year Keira Reynolds was in a vastly different place to where she is today. Back then, the Year 6 student was coming to grips with a new type 1 diabetes diagnosis and finishing primary school, uncertain about what lay ahead at high school.

New hope for type 1 diabetes

Type 1 diabetes is exhausting and unrelenting. It can be life threatening and there is never a break from it.

Maths, modelling and RSV: the unique combo driving virus prevention

The Kids Research Institute developed a world-first RSV transmission model using real data to predict the impact of WA’s immunisation program for young children.

Study suggests flu vaccine may take edge off RSV cases

A The Kids Research Institute Australia study has suggested the seasonal flu vaccine for children could also protect them from respiratory syncytial virus (RSV), with the dual benefit easing pressure on hospitals.

Hep C can be cured, but many people are still not being treated

People living with hepatitis C in WA are being urged to take part in a new project, aimed at encouraging the take-up of treatment. 

Predominance of nontypeable haemophilus influenzae in children with otitis media

In Australia the 7-valent pneumococcal conjugate vaccine (PCV7) is administered at 2, 4 and 6 months of age, with no booster dose.

Costs of primary healthcare presentations and hospital admissions for scabies and related skin infections in Fiji, 2018–2019

Scabies and related bacterial skin and soft tissue infections are highly prevalent in many tropical, low- and middle-income settings. These skin conditions contribute to higher healthcare costs and burdens on healthcare systems.